IGM Biosciences Inc
NASDAQ:IGMS
IGM Biosciences Inc
NASDAQ:IGMS
Price:
1.27
USD
-2.31%
Market Cap:
$76.6m
Balance Sheet
Balance Sheet Decomposition
IGM Biosciences Inc
IGM Biosciences Inc
Balance Sheet Decomposition is not available for
IGM Biosciences Inc
IGM Biosciences Inc
Balance Sheet
IGM Biosciences Inc
IGM Biosciences Inc
Currency: USD
| Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
0
|
2
|
36
|
241
|
133
|
121
|
113
|
26
|
|
| Cash Equivalents |
0
|
2
|
36
|
241
|
133
|
121
|
113
|
26
|
|
| Short-Term Investments |
0
|
0
|
189
|
125
|
96
|
306
|
225
|
157
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
1
|
6
|
7
|
11
|
11
|
10
|
10
|
|
| Total Current Assets |
1
|
2
|
231
|
373
|
241
|
438
|
348
|
194
|
|
| PP&E Net |
1
|
2
|
18
|
35
|
56
|
73
|
74
|
71
|
|
| PP&E Gross |
1
|
2
|
18
|
35
|
56
|
73
|
74
|
71
|
|
| Accumulated Depreciation |
0
|
1
|
1
|
2
|
7
|
12
|
21
|
29
|
|
| Long-Term Investments |
0
|
0
|
12
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
1
|
1
|
2
|
2
|
1
|
|
| Total Assets |
1
N/A
|
4
+186%
|
261
+6 435%
|
409
+56%
|
298
-27%
|
514
+72%
|
423
-18%
|
266
-37%
|
|
| Liabilities | |||||||||
| Accounts Payable |
0
|
0
|
3
|
8
|
6
|
3
|
1
|
1
|
|
| Accrued Liabilities |
1
|
4
|
6
|
9
|
22
|
39
|
37
|
34
|
|
| Short-Term Debt |
0
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
3
|
4
|
3
|
|
| Total Current Liabilities |
1
|
9
|
9
|
17
|
28
|
45
|
42
|
38
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
12
|
10
|
25
|
182
|
178
|
180
|
|
| Total Liabilities |
1
N/A
|
9
+709%
|
21
+137%
|
27
+27%
|
53
+99%
|
226
+325%
|
220
-3%
|
218
-1%
|
|
| Equity | |||||||||
| Common Stock |
41
|
61
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Retained Earnings |
41
|
64
|
107
|
189
|
354
|
575
|
821
|
1 017
|
|
| Additional Paid In Capital |
36
|
1
|
347
|
570
|
598
|
862
|
1 024
|
1 064
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Other Equity |
35
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
0
N/A
|
5
N/A
|
240
N/A
|
382
+59%
|
245
-36%
|
287
+17%
|
203
-29%
|
48
-76%
|
|
| Total Liabilities & Equity |
1
N/A
|
4
+186%
|
261
+6 435%
|
409
+56%
|
298
-27%
|
514
+72%
|
423
-18%
|
266
-37%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
29
|
29
|
37
|
32
|
33
|
43
|
59
|
60
|
|
Switch to:
Switch to:
See Also
Discover More
